WHO PACKAGE INSERT
Synflorix™ Page 4 of 9 WHO Package insert (Final) For children at high-risk for pneumococcal disease (such as children with sickle cell disease, asplenia,
Tags:
Packages, Insert, Pneumococcal, Who package insert
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
Pneumococcal Contraindications - WHO/OMS: Extranet …
extranet.who.intContraindications Pneumococcal vaccines (WHO position paper) There are no absolute contraindications to vaccination with pneumococcal polysaccharide vaccine except for an anaphylactic reaction to the previous
Pneumococcal, Contraindications, Pneumococcal contraindications, Contraindications pneumococcal
Varicella Contraindications - WHO/OMS: Extranet Systems
extranet.who.intContraindications Varicella vaccines (WHO position paper) In immunocompromised persons, including patients with advanced HIV infection, varicella vaccination is currently contraindicated for fear of
VACCINE SAFETY AND FALSE CONTRAINDICATIONS TO ... - …
www.euro.who.intAbstract Health professionals are the single most important influence on whether individuals decide to have themselves or their children vaccinated; therefore, …
Guide to Contraindications and Precautions to Commonly ...
www.immunize.orgSevere allergic reaction (e.g., anaphylaxis) after a previ-ous dose or to a vaccine component • Hypersensitivity to yeast • Moderate or severe acute illness with or without fever
Pneumococcal Polysaccharide Clinical Guidelines
www.albertahealthservices.ca1 Alberta Health Services Immunization Program October17, 2014 Pneumococcal Polysaccharide Immunization Clinical Guidelines 2014/2015 Pneumococcal polysaccharide vaccine is used to prevent serious illness caused by the
Guidelines, Clinical, Pneumococcal, Polysaccharide, Pneumococcal polysaccharide clinical guidelines
Administering Vaccines: Dose, Route, Site, and Needle Size
immunize.orgUse a 22–25 gauge needle. Choose the injection site and needle length that is appropriate to the person’s age and body mass.
VACCINE INFOR MATION - Department of Health
www.kznhealth.gov.zaFOR PARENTS & CAREGIVERS VACCINE INFOR MATION NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health …
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Indications and Use PNEUMOVAX® 23 is a vaccine indicated for active immunization for the prevention of ...
Information, Prescribing, Prescribing information, Pneumovax, 174 23